TN2010000421A1 - Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation - Google Patents

Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Info

Publication number
TN2010000421A1
TN2010000421A1 TNP2010000421A TN2010000421A TN2010000421A1 TN 2010000421 A1 TN2010000421 A1 TN 2010000421A1 TN P2010000421 A TNP2010000421 A TN P2010000421A TN 2010000421 A TN2010000421 A TN 2010000421A TN 2010000421 A1 TN2010000421 A1 TN 2010000421A1
Authority
TN
Tunisia
Prior art keywords
ebv
reactivation
epstein
synthetic peptide
barr virus
Prior art date
Application number
TNP2010000421A
Other languages
French (fr)
Inventor
Emmanuel Drouet
Original Assignee
Univ Joseph Fourier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/052798 external-priority patent/WO2009112497A1/en
Application filed by Univ Joseph Fourier filed Critical Univ Joseph Fourier
Publication of TN2010000421A1 publication Critical patent/TN2010000421A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention discloses the use of polypeptide derived from ZEBRA protein, or variants or isoforms of the said polypeptide for the in vitro and ex vivo screening of the EBV virus reactivation in a biological sample of a subject afflicted by a pathology associated with EBV infection.
TNP2010000421A 2009-03-10 2010-09-13 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation TN2010000421A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/052798 WO2009112497A1 (en) 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Publications (1)

Publication Number Publication Date
TN2010000421A1 true TN2010000421A1 (en) 2011-12-29

Family

ID=55024544

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000421A TN2010000421A1 (en) 2009-03-10 2010-09-13 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Country Status (1)

Country Link
TN (1) TN2010000421A1 (en)

Similar Documents

Publication Publication Date Title
CR20120026A (en) NEW CONSTRUCTIONS OF HUMAN PAPILOMA VIRUS PROTEIN (HPV) AND ITS USE IN THE PREVENTION OF HPV DISEASE
MX2009005788A (en) Truncated pth peptides with a cyclic conformation.
MX355268B (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF.
ATE548049T1 (en) USE OF IDES PROTEINASE (FROM S. PYOGENES) TO TREAT AUTOIMMUNE DISEASES AND TRANSPLANT REJECTION
TN2012000040A1 (en) High affinity human antibodies to human angiopoietin -2
IL222879A0 (en) Peptides for treatment and diagnosis of autoimmune disease
JO3330B1 (en) Cgrp antibodies
MX2010003380A (en) Heparin-binding epidermal growth factor-like growth factor antigen binding proteins.
WO2006086799A3 (en) Prion-specific peptide reagents
SG179095A1 (en) Novel assay for the detection of amyloid beta peptides
MY159398A (en) Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
IL210364A (en) Cyclic peptide analogue of the ß-amyloid peptide and uses thereof in the treatment or diagnosis of neurodegenerative diseases or conditions
MY156432A (en) Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation
WO2006082304A3 (en) Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof
MX2009001937A (en) Biomarkers for alzheimer's disease progression.
MY155340A (en) Use of cathepsin c
EA201291345A1 (en) CITRULINATED HISTON PEPTIDES AND THEIR APPLICATION
EP2371840A4 (en) Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
EP2281003A4 (en) Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
TN2010000421A1 (en) Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation
GB2530224A (en) Enhancement of osteogenic potential of bone grafts
MY151307A (en) Peptides having antimicrobial activity
DK2118136T3 (en) consensus Peptide
MX2016002556A (en) Methods and compositions for treatment of cartilage and disc tissue pathologies.
SG178929A1 (en) Use of cathepsin h